CN Patent

CN101784269A — 治疗由5-羟色胺介导的疾病和病症的方法

Assigned to Lexicon Pharmaceuticals Inc · Expires 2010-07-21 · 16y expired

What this patent protects

本文公开了可用于治疗由5-羟色胺介导的疾病和病症的化合物。

USPTO Abstract

本文公开了可用于治疗由5-羟色胺介导的疾病和病症的化合物。

Drugs covered by this patent

telotristat-etiprate (TELOTRISTAT ETIPRATE)

Patent Metadata

Patent number: CN101784269A
Jurisdiction: CN
Classification: —
Expires: 2010-07-21
Drug substance claim: No
Drug product claim: No
Assignee: Lexicon Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.